哮喘药物基因组学的全基因组关联研究进展
Advances in Genome-Wide Association Study on Asthma Pharmacogenomics
DOI: 10.12677/acm.2024.143900, PDF,    科研立项经费支持
作者: 王 钦, 任 洛, 刘恩梅*：重庆医科大学附属儿童医院呼吸科，国家儿童健康与疾病临床医学研究中心，儿童发育疾病研究教育部重点实验室，儿科学重庆市重点实验室，重庆
关键词: 哮喘；药物基因组学；GWAS；Asthma； Pharmacogenomics； GWAS
摘要: 支气管哮喘(简称哮喘)是一种复杂的多因素疾病。哮喘患者对药物的治疗反应具有个体差异，部分原因由遗传因素决定。药物基因组学主要是研究人类基因组信息与药物反应之间的关系。全基因组关联研究(GWAS)可以分析大样本量及复杂疾病与基因的关联，是药物基因组学研究的新方法。目前，哮喘的GWAS已经指出一些具有潜在希望的基因变异。本文就抗哮喘药物治疗反应性相关GWAS的研究进行综述，以介绍哮喘药物基因组学的进展。
Abstract: Bronchial asthma is a complex multifactorial disease. Individual differences in the therapeutic response to medications in asthmatics are partly determined by genetic factors. The focus of pharmacogenomics is on the relationship between human genomic information and drug response. Genome-wide association studies (GWAS), which can analyze the relationship between complex diseases and genes in large sample sizes, are a novel approach to pharmacogenomic research. GWAS have identified some potentially promising genetic variants for asthma. This article provides a review of studies on GWAS related to therapeutic responsiveness to anti-asthma medications in order to present advances in asthma pharmacogenomics.
文章引用：王钦, 任洛, 刘恩梅. 哮喘药物基因组学的全基因组关联研究进展[J]. 临床医学进展, 2024, 14(3): 1724-1732. https://doi.org/10.12677/acm.2024.143900

参考文献

[1] Mims, J.W. (2015) Asthma: Definitions and Pathophysiology. International Forum of Allergy & Rhinology, 5, S2-S6. [Google Scholar] [CrossRef] [PubMed]
[2] (2020) Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet, 396, 1204-1222.
[3] 林江涛, 王文巧, 周新, 等. 我国30个省市城区门诊支气管哮喘患者控制水平的调查结果[J]. 中华结核和呼吸杂志, 2017, 40(7): 494-498.
[4] Roden, D.M., McLeod, H.L., Relling, M.V., et al. (2019) Pharmacogenomics. The Lancet, 394, 521-532. [Google Scholar] [CrossRef] 
[5] Turner, S., Francis, B., Vijverberg, S., et al. (2016) Childhood Asthma Exacerbations and the Arg16 β2-Receptor Polymorphism: A Meta-Analysis Stratified by Treatment. Journal of Allergy and Clinical Immunology, 138, 107-113.E5. [Google Scholar] [CrossRef] [PubMed]
[6] Ober, C. and Yao, T.C. (2011) The Genetics of Asthma and Allergic Disease: A 21st Century Perspective. Immunological Reviews, 242, 10-30. [Google Scholar] [CrossRef] 
[7] Dehghan, A. (2018) Genome-Wide Association Studies. Methods in Molecular Biology, 1793, 37-49. [Google Scholar] [CrossRef] [PubMed]
[8] Adikusuma, W., Chou, W.H., Lin, M.R., et al. (2022) Identification of Druggable Genes for Asthma by Integrated Genomic Network Analysis. Biomedicines, 10, Article No. 113. [Google Scholar] [CrossRef] [PubMed]
[9] Barnes, P.J., Greening, A.P. and Crompton, G.K. (1995) Glucocorticoid Resistance in Asthma. American Journal of Respiratory and Critical Care Medicine, 152, S125-S140. [Google Scholar] [CrossRef] 
[10] Henderson, I., Caiazzo, E., McSharry, C., et al. (2020) Why Do Some Asthma Patients Respond Poorly to Glucocorticoid Therapy? Pharmacological Research, 160, Article ID: 105189. [Google Scholar] [CrossRef] [PubMed]
[11] Tantisira, K.G., Lasky-Su, J., Harada, M., et al. (2011) Genomewide Association between GLCCI1 and Response to Glucocorticoid Therapy in Asthma. The New England Journal of Medicine, 365, 1173-1183. [Google Scholar] [CrossRef] 
[12] Tantisira, K.G., Damask, A., Szefler, S.J., et al. (2012) Genome-Wide Association Identifies the T Gene as a Novel Asthma Pharmacogenetic Locus. American Journal of Respiratory and Critical Care Medicine, 185, 1286-1291. [Google Scholar] [CrossRef] 
[13] Park, H.W., Dahlin, A., Tse, S., et al. (2014) Genetic Predictors Associated with Improvement of Asthma Symptoms in Response to Inhaled Corticosteroids. Journal of Allergy and Clinical Immunology, 133, 664-669.E5. [Google Scholar] [CrossRef] [PubMed]
[14] Wu, A.C., Himes, B.E., Lasky-Su, J., et al. (2014) Inhaled Corticosteroid Treatment Modulates ZNF432 Gene Variant’s Effect on Bronchodilator Response in Asthmatics. Journal of Allergy and Clinical Immunology, 133, 723-728.E3. [Google Scholar] [CrossRef] [PubMed]
[15] Dahlin, A., Denny, J., Roden, D.M., et al. (2015) CMTR1 Is Associated with Increased Asthma Exacerbations in Patients Taking Inhaled Corticosteroids. Immunity, Inflammation and Disease, 3, 350-359. [Google Scholar] [CrossRef] [PubMed]
[16] Mosteller, M., Hosking, L., Murphy, K., et al. (2017) No Evidence of Large Genetic Effects on Steroid Response in Asthma Patients. Journal of Allergy and Clinical Immunology, 139, 797-803.E7. [Google Scholar] [CrossRef] [PubMed]
[17] Hernandez-Pacheco, N., Farzan, N., Francis, B., et al. (2019) Genome-Wide Association Study of Inhaled Corticosteroid Response in Admixed Children with Asthma. Clinical & Experimental Allergy, 49, 789-798. [Google Scholar] [CrossRef] [PubMed]
[18] Hernandez-Pacheco, N., Vijverberg, S.J., Herrera-Luis, E., et al. (2021) Genome-Wide Association Study of Asthma Exacerbations despite Inhaled Corticosteroid Use. European Respiratory Journal, 57, Article ID: 2003388.
[19] Park, T.J., Park, J.S., Cheong, H.S., et al. (2014) Genome-Wide Association Study Identifies ALLC Polymorphisms Correlated with FEV1 Change by Corticosteroid. Clinica Chimica Acta, 436, 20-26. [Google Scholar] [CrossRef] [PubMed]
[20] Wang, Y., Tong, C., Wang, Z., et al. (2015) Pharmacodynamic Genome-Wide Association Study Identifies New Responsive Loci for Glucocorticoid Intervention in Asthma. The Pharmacogenomics Journal, 15, 422-429. [Google Scholar] [CrossRef] [PubMed]
[21] Finkelstein, Y., Bournissen, F.G., Hutson, J.R., et al. (2009) Polymorphism of the ADRB2 Gene and Response to Inhaled Beta-Agonists in Children with Asthma: A Meta-Analysis. Journal of Asthma, 46, 900-905. [Google Scholar] [CrossRef] [PubMed]
[22] Poon, A.H., Tantisira, K.G., Litonjua, A.A., et al. (2008) Association of Corticotropin-Releasing Hormone Receptor-2 Genetic Variants with Acute Bronchodilator Response in Asthma. Pharmacogenetics and Genomics, 18, 373-382. [Google Scholar] [CrossRef] 
[23] Dragicevic, S., Kosnik, M., Divac Rankov, A., et al. (2018) The Variants in the 3’ Untranslated Region of the Matrix Metalloproteinase 9 Gene as Modulators of Treatment Outcome in Children with Asthma. Lung, 196, 297-303. [Google Scholar] [CrossRef] [PubMed]
[24] Litonjua, A.A., Lasky-Su, J., Schneiter, K., et al. (2008) ARG1 Is a Novel Bronchodilator Response Gene: Screening and Replication in Four Asthma Cohorts. American Journal of Respiratory and Critical Care Medicine, 178, 688-694. [Google Scholar] [CrossRef] 
[25] Himes, B.E., Jiang, X., Hu, R., et al. (2012) Genome-Wide Association Analysis in Asthma Subjects Identifies SPATS2L as a Novel Bronchodilator Response Gene. PLOS Genetics, 8, E1002824. [Google Scholar] [CrossRef] [PubMed]
[26] Duan, Q.L., Lasky-Su, J., Himes, B.E., et al. (2014) A Genome-Wide Association Study of Bronchodilator Response in Asthmatics. The Pharmacogenomics Journal, 14, 41-47. [Google Scholar] [CrossRef] [PubMed]
[27] Israel, E., Lasky-Su, J., Markezich, A., et al. (2015) Genome-Wide Association Study of Short-Acting β2-Agonists. A Novel Genome-Wide Significant Locus on Chromosome 2 near ASB3. American Journal of Respiratory and Critical Care Medicine, 191, 530-537. [Google Scholar] [CrossRef] 
[28] Drake, K.A., Torgerson, D.G., Gignoux, C.R., et al. (2014) A Genome-Wide Association Study of Bronchodilator Response in Latinos Implicates Rare Variants. Journal of Allergy and Clinical Immunology, 133, 370-378. [Google Scholar] [CrossRef] [PubMed]
[29] Padhukasahasram, B., Yang, J.J., Levin, A.M., et al. (2014) Gene-Based Association Identifies SPATA13-AS1 as a Pharmacogenomic Predictor of Inhaled Short-Acting Beta-Agonist Response in Multiple Population Groups. The Pharmacogenomics Journal, 14, 365-371. [Google Scholar] [CrossRef] [PubMed]
[30] Spear, M.L., Hu, D., Pino-Yanes, M., et al. (2019) A Genome-Wide Association and Admixture Mapping Study of Bronchodilator Drug Response in African Americans with Asthma. The Pharmacogenomics Journal, 19, 249-259. [Google Scholar] [CrossRef] [PubMed]
[31] Mak, A., White, M.J., Eckalbar, W.L., et al. (2018) Whole-Genome Sequencing of Pharmacogenetic Drug Response in Racially Diverse Children with Asthma. American Journal of Respiratory and Critical Care Medicine, 197, 1552-1564. [Google Scholar] [CrossRef] 
[32] Perez-Garcia, J., Espuela-Ortiz, A., Lorenzo-Diaz, F., et al. (2020) Pharmacogenetics of Pediatric Asthma: Current Perspectives. Pharmacogenomics and Personalized Medicine, 13, 89-103. [Google Scholar] [CrossRef] 
[33] GINA Executive and Science Committee (2023) Global Strategy for Asthma Management and Prevention 2023.
http://www.gina.com
[34] Reddel, H.K., Bacharier, L.B., Bateman, E.D., et al. (2022) Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes. European Respiratory Journal, 59, Article ID: 2102730. [Google Scholar] [CrossRef] [PubMed]
[35] Zuurhout, M.J., Vijverberg, S.J., Raaijmakers, J.A., Koenderman, L., Postma, D.S., Koppelman, G.H. and Maitland-van der Zee, A.H. (2013) Arg16 ADRB2 Genotype Increases the Risk of Asthma Exacerbation in Children with a Reported Use of Long-Acting β2-Agonists: Results of the PACMAN Cohort. Pharmacogenomics, 14, 1965-1971. [Google Scholar] [CrossRef] [PubMed]
[36] Kim, S.H., Ye, Y.M., Lee, H.Y., et al. (2011) Combined Pharmacogenetic Effect of ADCY9 and ADRB2 Gene Polymorphisms on the Bronchodilator Response to Inhaled Combination Therapy. Journal of Clinical Pharmacy and Therapeutics, 36, 399-405. [Google Scholar] [CrossRef] [PubMed]
[37] Liang, S., Wei, X., Gong, C., et al. (2013) A Disintegrin and Metalloprotease 33 (ADAM33) Gene Polymorphisms and the Risk of Asthma: A Meta-Analysis. Human Immunology, 74, 648-657. [Google Scholar] [CrossRef] [PubMed]
[38] Slob, E., Richards, L.B., Vijverberg, S., et al. (2021) Genome-Wide Association Studies of Exacerbations in Children Using Long-Acting Beta2-Agonists. Pediatric Allergy and Immunology, 32, 1197-1207. [Google Scholar] [CrossRef] [PubMed]
[39] Farzan, N., Vijverberg, S.J., Arets, H.G., et al. (2017) Pharmacogenomics of Inhaled Corticosteroids and Leukotriene Modifiers: A Systematic Review. Clinical & Experimental Allergy, 47, 271-293. [Google Scholar] [CrossRef] [PubMed]
[40] Dahlin, A., Litonjua, A., Irvin, C.G., et al. (2016) Genome-Wide Association Study of Leukotriene Modifier Response in Asthma. The Pharmacogenomics Journal, 16, 151-157. [Google Scholar] [CrossRef] [PubMed]
[41] 朱桂萍, 叶伶, 金美玲. 支气管哮喘靶向治疗的研究进展[J]. 国际呼吸杂志, 2021, 41(7): 529-535.
[42] El-Husseini, Z.W., Gosens, R., Dekker, F., et al. (2020) The Genetics of Asthma and the Promise of Genomics-Guided Drug Target Discovery. The Lancet Respiratory Medicine, 8, 1045-1056. [Google Scholar] [CrossRef] 
[43] Chapman, M.S., Askew, D.J., Kuscuoglu, U., et al. (1996) Transcriptional Control of Steroid-Regulated Apoptosis in Murine Thymoma Cells. Molecular Endocrinology, 10, 967-978. [Google Scholar] [CrossRef] [PubMed]
[44] Hu, C., Xun, Q., Li, X., et al. (2016) GLCCI1 Variation Is Associated with Asthma Susceptibility and Inhaled Corticosteroid Response in a Chinese Han Population. Archives of Medical Research, 47, 118-125. [Google Scholar] [CrossRef] [PubMed]
[45] Izuhara, Y., Matsumoto, H., Kanemitsu, Y., et al. (2014) GLCCI1 Variant Accelerates Pulmonary Function Decline in Patients with Asthma Receiving Inhaled Corticosteroids. Allergy, 69, 668-673. [Google Scholar] [CrossRef] [PubMed]
[46] Hikino, K., Kobayashi, S., Ota, E., et al. (2021) A Meta-Analysis of the Influence of ADRB2 Genetic Polymorphisms on Albuterol (Salbutamol) Therapy in Patients with Asthma. British Journal of Clinical Pharmacology, 87, 1708-1716. [Google Scholar] [CrossRef] [PubMed]
[47] Slob, E., Vijverberg, S., Palmer, C., et al. (2018) Pharmacogenetics of Inhaled Long-Acting Beta2-Agonists in Asthma: A Systematic Review. Pediatric Allergy and Immunology, 29, 705-714. [Google Scholar] [CrossRef] [PubMed]
[48] Ortega, V.E. and Meyers, D.A. (2014) Pharmacogenetics: Implications of Race and Ethnicity on Defining Genetic Profiles for Personalized Medicine. Journal of Allergy and Clinical Immunology, 133, 16-26. [Google Scholar] [CrossRef] [PubMed]
[49] Cazzola, M., Calzetta, L., Matera, M.G., et al. (2018) How Does Race/Ethnicity Influence Pharmacological Response to Asthma Therapies? Expert Opinion on Drug Metabolism & Toxicology, 14, 435-446. [Google Scholar] [CrossRef] [PubMed]
[50] Tam, V., Patel, N., Turcotte, M., et al. (2019) Benefits and Limitations of Genome-Wide Association Studies. Nature Reviews Genetics, 20, 467-484. [Google Scholar] [CrossRef] [PubMed]

为你推荐